Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Contraceptive Drugs And Devices Market Size Expansion: A Snapshot of Growth Between 2024 and 2029
Over the past few years, there has been substantial growth in the size of the contraceptive drugs and devices market. Projected growth is from $25.3 billion in 2024 to $26.98 billion in 2025 with a CAGR of 6.7%. Key factors contributing to the impressive growth during the historic period include population growth, heightened family planning awareness, government initiatives and funding, a rise in the number of working women, and technological advancements in the field of contraception.
Over the next few years, it is anticipated that the contraceptive drugs and devices market will witness substantial growth. It is projected to escalate to $35.55 billion in 2029 with a compound annual growth rate (CAGR) of 7.1%. The forecasted expansion can be chalked up to several factors, such as the growing preference for long-acting reversible contraceptives, greater emphasis on female reproductive health, a rise in sexually transmitted infections, broader access via online platforms and telehealth, supportive healthcare regulations, and insurance coverage. As for the upcoming trends, expect to see smart contraceptive devices equipped with digital tracking, biodegradable implants and patches, innovations in hormone-free contraceptives, fertility monitoring apps powered by artificial intelligence, and 3d printing of tailor-made contraceptive devices.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
Key Drivers Behind the Expansion of the Contraceptive Drugs And Devices Market: Insights and Trends
Growth in the contraceptive drugs and devices market is forecasted to be influenced by increased governmental initiatives concerning reproductive health. These initiatives aim to foster reproductive health by encouraging consciousness, funding, and availability of services. The need to address critical matters such as maternal health, access to necessary healthcare facilities, and family planning fuels the rise of governmental interventions concerning reproductive health, thereby influencing the collective health and progression of society.
Efforts of the government towards contraceptive drugs and devices revolve around enhancing accessibility to affordable and successful family planning techniques, confirming well-informed decisions regarding reproductive health by individuals. The Australian Government Department of Foreign Affairs and Trade, in November 2024, is set to allocate $56.8 million for a new proposal designed to advocate for sexual and reproductive health and rights in Southeast Asia, as an example. Consequently, the escalated count of governmental initiatives regarding reproductive health propels the growth of the contraceptive drugs and devices market.
Which Segments in the Contraceptive Drugs And Devices Industry Are Seeing the Fastest Growth?
The contraceptive drugs and devices market covered in this report is segmented –
1) By Product: Contraceptive Drugs, Contraceptive Devices
2) By Technology: Traditional Methods, Digital Contraceptive Apps, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels
4) By End User: Male, Female
Subsegments:
1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants
2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
Which New Trends Will Create Growth Opportunities in the Contraceptive Drugs And Devices Market?
The contraceptive drugs and devices market is witnessing progressive strides by leading companies who are venturing into the creation of novel products such as contraceptive vaginal rings, aimed at augmenting user-friendliness and amplifying available options of long-lasting contraceptives. The ring is a pliant, hormone-distributing gadget inserted into the vagina to thwart pregnancy by obstructing ovulation. Specifically, in October 2023, Xiromed LLC, a pharmaceutical firm based in the US, brought to market EnilloRing, a tender, supple, contraceptive vaginal ring constructed to be embedded into the vagina. It maintains a constant release of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) for a period of three weeks to inhibit ovulation. Being a bioequivalent generic to NuvaRing, it grants women an accessible, unnoticeable, and competitively priced monthly birth control alternative. It eradicates the requirement for daily dosing while upholding the equivalent safety, potency, and bearability as the branded precedent.
Which Global Regions Are Powering Demand in the Contraceptive Drugs And Devices Market?
North America was the largest region in the contraceptive drugs and devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
How Key Players Are Driving Growth in the Contraceptive Drugs And Devices Market?
Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=24197
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
